With the RoSS.FILL CGT system, Single Use Support delivers unprecedented filling accuracy for aseptic aliquoting of advanced therapies into single-use bags. Dive into state-of-the-art, scalable ATMP fluid management with 21 CFR Part 11 reproducible accuracy.

• Attracting, recruiting and retaining experienced staff remains a key priority for companies.
• Recruitment strategies: Actively seeking out talent from diverse backgrounds and ensuring that recruitment practices are free from bias.
• Mentorship programs: Pairing young professionals with seasoned executives to ensure the next generation of leadership is as diverse as the populations they serve.
• Early talent and how to invest and engage early to ensure we don’t leave people out of this potential pipeline.
• Consortiums and Associations - Investing in early career programmes to create employment pathways.
• Finding talent to fuel innovation - Increasingly seeking talent with AI and data skills in order to remain competitive as digital technology drives innovations
• How can pharma companies support early career scientists through non-traditional pathways into the industry?
• The impact of digitalisation: What skills will give new hires an edge?
• Industry growth and its implications for career development

This presentation delves into the critical aspects of late-stage characterization for antibody-drug conjugates (ADCs) and their role in a robust analytical control strategy essential for successful marketing applications. Starting with an explanation of product characterization and its necessity, we outline its integration into the control strategy, highlighting its role from preclinical development through to commercial production.

Key topics include:

1. Product Characterization: Importance, steps, and impact on safety, efficacy, stability, and performance.

2. Control Strategy Integration: How characterization supports the Quality Target Product Profile (QTPP) and defines critical quality attributes (CQAs).

3. Case Study: An ADC characterization project at KBI Biopharma, showcasing methodologies, challenges, and data analysis.

• What contributes to fostering a truly inclusive work environment?
• Building and sustaining a truly inclusive workplace
• Why is there more focus on DE&I- what is contributing?
• Adopting employee-focused innovative initiatives
• While multinational pharma companies like these are devoting more resources to diversity and inclusion initiatives internally, what impact will this have more widely?
• Why diversity in pharma leadership matters
• What is driving DE&I for talent today?
• Continual education: Regular training sessions on unconscious bias, cultural sensitivity, and the importance of D&I for all employees.
• Embracing D&I will not only lead to a more inclusive industry but also a more prosperous and innovative one.

• How can early-stage/research professionals best prepare for GMP
• Critical aspects to keep in mind transitioning from early-stage development into more commercial manufacturing.
• Examples from experiences and lessons learnt
• Cross-team collaboration and pre-emptively preventing down the road bottlenecks

• How can early-stage/research professionals best prepare for GMP
• Critical aspects to keep in mind transitioning from early-stage development into more commercial manufacturing.
• Examples from experiences and lessons learnt
• Cross-team collaboration and pre-emptively preventing down the road bottlenecks